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Background
Glycogen synthesis kinase 3b (GSK3b) has been shown to
be a critical mediator of the intensity and direction of the
innate immune system responding to bacterial stimuli.
Stimulation of the anti-cholinergic anti-inflammatory
system by tobacco alkaloids (nicotine; cotinine) leads to
phosphorylation and inactivation of GSK3b and, subse-
quently, to immune suppression. This presentation will
review the tobacco-induced dysregulation of GSK3b sig-
naling and provide insight into the increased susceptibil-
ity of smokers to multiple bacterial diseases, including
those caused by Mycobacterium tuberculosis, Legionella
pneumophila, and Neisseria meningitidis. The extensive
ongoing efforts to exploit GSK3b for its therapeutic
potential in the control of infectious diseases will also be
reviewed.
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